{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:01:00Z","timestamp":1790168460886,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06320-4","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:26:07Z","timestamp":1783005967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic challenge of occult ER-positive breast carcinoma within bone marrow indolent B-cell lymphoma and response to CDK4\/6 inhibitor: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Denise","family":"Drittone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mariniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Noccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Maiorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto","family":"La Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Mazzuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pisegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"1","key":"6320_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD. Breast cancer: pathogenesis and treatments. Signal Transduction Target Ther. 2025;10(1):49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Signal Transduction Target Ther"},{"issue":"6","key":"6320_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/cells10061377","volume":"10","author":"K Venetis","year":"2021","unstructured":"Venetis K, Piciotti R, Sajjadi E, Invernizzi M, Morganti S, Criscitiello C, Fusco N. Breast cancer with bone metastasis: molecular insights and clinical management. Cells. 2021;10(6):1377. https:\/\/doi.org\/10.3390\/cells10061377.","journal-title":"Cells"},{"issue":"9","key":"6320_CR3","doi-asserted-by":"publisher","first-page":"10672","DOI":"10.1002\/cam4.5827","volume":"12","author":"L Niu","year":"2023","unstructured":"Niu L, Lv H, Zhang M, et al. Clinicopathological features and prognosis of breast cancer combined with symptomatic bone marrow metastases: a 10-year, single-center, real-world study of 67 cases. Cancer Med. 2023;12(9):10672\u201383. https:\/\/doi.org\/10.1002\/cam4.5827.","journal-title":"Cancer Med"},{"issue":"1","key":"6320_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12288-021-01418-9","volume":"38","author":"HS Rani","year":"2022","unstructured":"Rani HS, Hui M, Manasa PL, Uppin SG, Uppin MS, Paul TR, Sadashivudu G. Bone marrow metastasis of solid tumors: a study of 174 cases over 2 decades from a single institution in India. Indian J Hematol Blood Transfus. 2022;38(1):8\u201314. https:\/\/doi.org\/10.1007\/s12288-021-01418-9.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"6320_CR5","doi-asserted-by":"publisher","first-page":"1570355","DOI":"10.3389\/fonc.2025.1570355","volume":"15","author":"C Zheng","year":"2025","unstructured":"Zheng C, Dai J, Wang Y, Zheng D, Lin R, Zheng Z. Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report and literature review. Front Oncol. 2025;15:1570355. https:\/\/doi.org\/10.3389\/fonc.2025.1570355.","journal-title":"Front Oncol"},{"issue":"2","key":"6320_CR6","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","volume":"2","author":"A Vogt","year":"2017","unstructured":"Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2):e000172. https:\/\/doi.org\/10.1136\/esmoopen-2017-000172.","journal-title":"ESMO Open"},{"issue":"1","key":"6320_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000421-200302000-00015","volume":"26","author":"CG Demandante","year":"2003","unstructured":"Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26(1):79\u201383. https:\/\/doi.org\/10.1097\/00000421-200302000-00015.","journal-title":"Am J Clin Oncol"},{"key":"6320_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1471-2407-14-272","volume":"14","author":"A Coyte","year":"2014","unstructured":"Coyte A, Morrison DS, McLoone P. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014;14:272. https:\/\/doi.org\/10.1186\/1471-2407-14-272.","journal-title":"BMC Cancer"},{"issue":"6","key":"6320_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ejca.2008.11.030","volume":"45","author":"S Rosso","year":"2009","unstructured":"Rosso S, De Angelis R, Ciccolallo L, Carrani E, Soerjomataram I, Grande E, Zigon G, Brenner H. Multiple tumours in survival estimates. Eur J Cancer. 2009;45(6):1080\u201394. https:\/\/doi.org\/10.1016\/j.ejca.2008.11.030.","journal-title":"Eur J Cancer"},{"issue":"8","key":"6320_CR10","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/pon.3227","volume":"22","author":"MS Thong","year":"2013","unstructured":"Thong MS, Mols F, Verhoeven RH, Liu L, Andrykowski MA, Roukema JA, van de Poll-Franse LV. Multiple primary cancer survivors have poorer health status and well-being than single primary cancer survivors: a study from the population-based PROFILES registry. Psychooncology. 2013;22(8):1834\u201342. https:\/\/doi.org\/10.1002\/pon.3227.","journal-title":"Psychooncology"},{"issue":"1","key":"6320_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12672-023-00667-6","volume":"14","author":"Z Zhan","year":"2023","unstructured":"Zhan Z, Guo W, Li J, Wan X, Guo J, Bai O. Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma. Discov Oncol. 2023;14(1):54. https:\/\/doi.org\/10.1007\/s12672-023-00667-6.","journal-title":"Discov Oncol"},{"key":"6320_CR12","doi-asserted-by":"publisher","first-page":"107398","DOI":"10.1016\/j.ijscr.2022.107398","volume":"97","author":"SA Syamsu","year":"2022","unstructured":"Syamsu SA, Setiady R, Smaradania N, Prihantono IF, Faruk M. Synchronous breast cancer and non-Hodgkin lymphoma: a case report. Int J Surg Case Rep. 2022;97:107398. https:\/\/doi.org\/10.1016\/j.ijscr.2022.107398.","journal-title":"Int J Surg Case Rep"},{"key":"6320_CR13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01392","author":"HJ Burstein","year":"2021","unstructured":"Burstein HJ, Somerfield MR. Endocrine treatment and targeted therapy for hormone receptor-positive human epidermal growth factor receptor 2\u2013negative metastatic breast cancer: ASCO guideline update. J Clin Oncol. 2021. https:\/\/doi.org\/10.1200\/JCO.21.01392.","journal-title":"J Clin Oncol"},{"key":"6320_CR14","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1810527","volume":"379","author":"NC Turner","year":"2018","unstructured":"Turner NC, Slamon DJ. Overall survival with palbociclib and fulvestrant in advanced breast cancer. N Engl J Med. 2018;379:1926\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1810527.","journal-title":"N Engl J Med"},{"key":"6320_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1042773","volume":"12","author":"R Yang","year":"2022","unstructured":"Yang R, Jia L, Lu G, Lv Z, Cui J. Symptomatic bone marrow metastases in breast cancer: a retrospective cohort study. Front Oncol. 2022;12: 1042773. https:\/\/doi.org\/10.3389\/fonc.2022.1042773.","journal-title":"Front Oncol"},{"issue":"11","key":"6320_CR16","doi-asserted-by":"publisher","first-page":"e14883","DOI":"10.1097\/MD.0000000000014883","volume":"98","author":"S Ma","year":"2019","unstructured":"Ma S, Leckey BD Jr, Zhang WL, et al. Signet-ring cells in the bone marrow as an indication of cryptic metastasis of breast carcinoma: a case report. Medicine. 2019;98(11):e14883. https:\/\/doi.org\/10.1097\/MD.0000000000014883.","journal-title":"Medicine"},{"issue":"3","key":"6320_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/tbj.12264","volume":"20","author":"L Demir","year":"2014","unstructured":"Demir L, Akyol M, Bener S, et al. Prognostic evaluation of breast cancer patients with evident bone marrow metastasis. Breast J. 2014;20(3):279\u201387. https:\/\/doi.org\/10.1111\/tbj.12264.","journal-title":"Breast J"},{"issue":"16","key":"6320_CR18","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.7150\/jca.25482","volume":"9","author":"C Zhai","year":"2018","unstructured":"Zhai C, Cai Y, Lou F, Liu Z, Xie J, Zhou X, Wang Z, Fang Y, Pan H, Han W. Multiple primary malignant tumors - a clinical analysis of 15,321 patients with malignancies at a single center in China. J Cancer. 2018;9(16):2795\u2013801. https:\/\/doi.org\/10.7150\/jca.25482.","journal-title":"J Cancer"},{"issue":"1","key":"6320_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-025-01653-y","volume":"20","author":"N Zhu","year":"2025","unstructured":"Zhu N, Gao Y, Pan Y, Song L, Yang Y, Yin Y, Wang Y, Zhang L, Wu S, Yu G. Clinical analysis of lymphoma with malignant solid tumor simultaneously: a retrospective case series. Diagn Pathol. 2025;20(1): 54. https:\/\/doi.org\/10.1186\/s13000-025-01653-y.","journal-title":"Diagn Pathol"},{"issue":"10","key":"6320_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.clon.2008.08.005","volume":"20","author":"E Amir","year":"2008","unstructured":"Amir E, Ooi WS, Simmons C, et al. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies. Clin Oncol. 2008;20(10):763\u20138. https:\/\/doi.org\/10.1016\/j.clon.2008.08.005.","journal-title":"Clin Oncol"},{"issue":"4","key":"6320_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1043\/1543-2165(2008)132[587:RVNBMP]2.0.CO;2","volume":"132","author":"RP Hasserjian","year":"2008","unstructured":"Hasserjian RP. Reactive versus neoplastic bone marrow: problems and pitfalls. Arch Pathol Lab Med. 2008;132(4):587\u201394. https:\/\/doi.org\/10.1043\/1543-2165(2008)132[587:RVNBMP]2.0.CO;2.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"6320_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/MNM.0000000000000361","volume":"36","author":"EY Lee","year":"2015","unstructured":"Lee EY, Gill H, Wang Y, Kwong YL, Khong PL. Bone marrow uptake of indolent non-Hodgkin lymphoma on PET\/CT with histopathological correlation. Nucl Med Commun. 2015;36(10):1035\u201341. https:\/\/doi.org\/10.1097\/MNM.0000000000000361.","journal-title":"Nucl Med Commun"},{"issue":"34","key":"6320_CR23","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1038\/s41388-020-01391-z","volume":"39","author":"JM Buschhaus","year":"2020","unstructured":"Buschhaus JM, Humphries BA, Eckley SS, et al. Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow. Oncogene. 2020;39(34):5649\u201362. https:\/\/doi.org\/10.1038\/s41388-020-01391-z.","journal-title":"Oncogene"},{"issue":"1","key":"6320_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01018-6","volume":"14","author":"M Lumish","year":"2021","unstructured":"Lumish M, Falchi L, Imber BS, et al. How we treat mature B-cell neoplasms (indolent B-cell lymphomas). J Hematol Oncol. 2021;14(1): 5. https:\/\/doi.org\/10.1186\/s13045-020-01018-6.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"6320_CR25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3109\/10428194.2013.853298","volume":"55","author":"S Govi","year":"2014","unstructured":"Govi S, Christie D, Mappa S, et al. The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study). Leuk Lymphoma. 2014;55(8):1796\u20139. https:\/\/doi.org\/10.3109\/10428194.2013.853298.","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06320-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06320-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06320-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:56Z","timestamp":1790164976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06320-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6320"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06320-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9236922\/v1","asserted-by":"object"}]},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"565"}}